← ANALYSTS · TIPRANKS
Mike Kratky · Leerink Partners
Hits
46%
71 of 155 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+12.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
16
Buy / hold / sell: 10 / 6 / 0
Upside of the analyst’s targets
+26.1%
Average over 14 current targets, to the last price
The market’s answer to the ratings
−0.3%
Day-0 move against SPY in the rating’s direction, average over 16 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 07:55 | EWSPYEdwards Lifesciences · $50.8B | Reiterated | Buy | $100 → $101+1.0% | +16.6% | +1.6%next day −0.6% | ↗ |
| Oct 12on TipRanks 13:20 | AXGNIWMAxoGen · $2.1B | Reiterated | Buy | $52.00 | +50.2% | +2.8%next day −2.5% | ↗ |
| Oct 12on TipRanks 07:35 | BSXSPYBoston Scientific · $64.0B | Assigned | Buy | $60.00 → $55.00−8.3% | +23.9% | +2.7%next day −1.2% | ↗ |
| Oct 12on TipRanks 07:35 | PRCTIWMPROCEPT BioRobotics · $1.0B | Assigned | Hold | $21.00 → $20.00−4.8% | +13.8% | +6.4%next day −2.4% | ↗ |
| Oct 12on TipRanks 07:35 | ZBHSPYZimmer Biomet Holdings · $18.0B | Assigned | Hold | $106 → $97.00−8.5% | +2.1% | +3.5%next day −0.1% | ↗ |
| Oct 12on TipRanks 07:35 | PODDSPYInsulet · $9.6B | Assigned | Hold | $145 → $143−1.4% | +1.3% | +3.4%next day −1.2% | ↗ |
| Oct 12on TipRanks 07:35 | ISRGQQQSPYIntuitive Surgical · $151B | Assigned | Buy | $454 → $473+4.2% | +10.9% | +0.9%next day −1.3% | ↗ |
| Oct 12on TipRanks 07:35 | SYKSPYStryker · $112B | Assigned | Buy | $403 → $353−12.4% | +19.8% | +2.0%next day 0.0% | ↗ |
| Sep 28on TipRanks Sep 29 01:15 | EWSPYEdwards Lifesciences · $50.8B | Reiterated | Buy | $101 | +16.6% | +1.4%next day +1.6% · 5 days −0.7% | ↗ |
| Sep 17on TipRanks Sep 14 08:45 | BBNXIWMBeta Bionics, Inc. · $934M | Reiterated | Buy | $27.00 | +65.1% | +1.4%next day +15.4% · 5 days +29.8% | ↗ |
| Aug 6on TipRanks 07:35 | PODDSPYInsulet · $9.6B | Downgrade | Hold | $145 | +2.8% | +4.7%next day +0.7% · 5 days +3.9% | ↗ |
| Jul 30on TipRanks 06:20 | BSXSPYBoston Scientific · $64.0B | Reiterated | Buy | $74.00 → $60.00−18.9% | +35.2% | −1.8%next day +0.9% · 5 days +3.6% | ↗ |
| Jul 17on TipRanks 06:19 | ISRGQQQSPYIntuitive Surgical · $151B | Reiterated | Buy | $573 → $454−20.8% | +6.4% | −13.2%next day +2.4% · 5 days −1.7% | ↗ |
| Jul 10on TipRanks 13:15 | MDTSPYMedtronic · $122B | Reiterated | Buy | — | — | +1.4%next day +0.4% · 5 days +0.7% | ↗ |
| Jun 12on TipRanks Jun 11 06:15 | PRCTIWMPROCEPT BioRobotics · $1.0B | Downgrade | Hold | $31.00 → $29.00−6.5% | +65.1% | −6.5%next day −7.7% · 5 days −23.0% | ↗ |
| Apr 13on TipRanks 07:50 | ZBHSPYZimmer Biomet Holdings · $18.0B | Initiated | Hold | $101 | +6.3% | +1.4%next day 0.0% · 5 days −3.2% | ↗ |
| Apr 13on TipRanks 06:35 | SYKSPYStryker · $112B | Initiated | Buy | $410 | +39.1% | +1.4%next day −1.6% · 5 days −5.9% | ↗ |
| Jan 15on TipRanks 20:20 | PENPenumbra · $12.5B | Downgrade | Hold | $374 | +16.6% | +0.2%next day +3.4% · 5 days +2.2% | ↗ |
| Oct 16on TipRanks 04:00 | ABTSPYAbbott Laboratories · $178B | Reiterated | Hold | $136 | +29.7% | −0.7%next day +0.1% · 5 days −2.7% | ↗ |
| Oct 14on TipRanks Jan 1 09:40 | DXCMQQQSPYDexcom · $31.5B | Reiterated | Buy | $85.00 → $84.00−1.2% | −2.4% | +1.7%next day −1.7% · 5 days +4.0% | |
| Oct 14on TipRanks Oct 16 04:05 | INSPIWMInspire Medical Systems · $2.0B | Reiterated | Hold | $97.00 → $96.00−1.0% | +39.6% | +1.6%next day −0.4% · 5 days +3.6% | ↗ |
| Oct 14on TipRanks Oct 16 04:00 | TNDMIWMTandem Diabetes Care · $1.1B | Reiterated | Buy | $32.00 → $29.00−9.4% | +78.6% | +3.8%next day +2.1% · 5 days +5.7% | ↗ |
| Oct 14on TipRanks Oct 16 03:50 | CRCIWMCalifornia Resources Corp · $4.7B | Reiterated | Buy | — | — | −3.0%next day −1.1% · 5 days −4.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗